Hymowitz Gregg's Form 4 filing
Flyexclusive Inc.FLYX · filed Mar 6, 2024
- Accession no.
- 0000950170-24-027446
- Filed
- Mar 6, 2024
- Trade date
- Mar 4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $25.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hymowitz GreggCIK 0001591141 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Series A Non-Convertible Redeemable Preferred Stock | PPurchaseAcquired | +25,000 | $1,000.00F1 | +$25,000,000 | 25,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Warrant (Right to Buy) | PPurchaseAcquired | +1 | –F1 | – | 1 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On March 4, 2024, EnTrust Emerald (Cayman) LP purchased 25,000 shares of Series A Non-Convertible Redeemed Preferred Stock, par value $0,0001 per share, together with a warrant to purchase a number of a shares of Common Stock equal to 1.5% of the Company's outstanding shares of Common Stock on a fully diluted basis as of the trading day prior to the delivery of the exercise notice (subject to the cap and other limitations discussed in Note 3, below), for a total purchase price of $25,000,000.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.